Peripheral artery disease (PAD), secondary to atherosclerotic disease, is currently the
leading cause of morbidity and mortality in the western world. While PAD is common, it is …

Lower extremity peripheral arterial disease (PAD) affects approximately 10% of the
American population, with 30% to 40% of these patients presenting with claudication …

The original TransAtlantic InterSociety Consensus (TASC) on the Management of Peripheral
Arterial Disease (PAD) published in 2000 was the first international consensus on the …

The prevalence of peripheral artery disease (PAD) is increasing worldwide and is strongly
age-related, affecting about 20% of Germans over 70 years of age. Recent advances in …

Peripheral arterial disease (PAD) is an atherosclerotic process that causes stenosis and
occlusion of non-cerebral and non-coronary arteries. It has an estimated worldwide …

The prevalence of peripheral arterial disease (PAD) is increasing worldwide, with recent
global estimates exceeding 200 million people. Advanced PAD leads to a decline in …

Peripheral arterial disease (PAD) represents a spectrum from asymptomatic stenosis to limb-
threatening ischemia. The last decade has seen a tremendous increase in the variety of …

Despite advances in medical therapies to help prevent the development of atherosclerosis
and improve the management of patients with established peripheral arterial disease (PAD) …

The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …

BACKGROUND: Endovascular therapy is a rapidly expanding option for the treatment of
patients with peripheral arterial disease (PAD), leading to a myriad of published studies …